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CHLORINATED LIPID INDUCE INFLAMMATORY RESPONSES 
IN THE MICROCIRCULATION 
Hong Yu 
Ronald J. Korthuis Thesis Supervisor 
ABSTRACT 
Previous studies from our research group have shown that chlorinated lipid, generated 
from the neutrophil-myeloperoxidase (MPO) system, are elevated in a rat sepsis model as 
well as in plasma of septic patients. Other work reported in multiple experimental studies 
and human trials have shown that microcirculatory dysfunction is a hallmark of sepsis. 
However, whether and how chlorinated lipid contribute to microcirculatory dysfunction 
are still unclear. In the current study, we hypothesized that compared to non-chlorinated 
lipid, chlorinated lipid could elicit inflammatory responses in the microcirculation.  
To test this postulate, a specific rat intravital model was developed. Briefly, male 
Sprague Dawley rats (250-300g) were randomly divided into 4 groups: 2-chloropalmitic 
acid (2-ClPA) group, 2-chloropalmitaldehyde (2-ClHDA) group, non-chlorinated palmitic 
acid (PA) group and palmitaldehyde (HDA) group (n=6). Rat mesenteries were 
exteriorized and superfused with 10 μM of 2-ClPA or 2-ClHDA, respectively. Equimolar 
concentrations of PA and HDA were applied as controls. Via use of our intravital 
microscopic approach, the indicators of microcirculatory dysfunction, leukocyte-
endothelial interactions (leukocyte rolling and adhesion), mast cell degranulation, reactive 
oxygen species (ROS) production, and albumin leakage were evaluated at 0 min (baseline), 
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20 min, 50 min and 80 min after the initiation of lipid superfusion, respectively. At the end 
of experiments, rats were sacrificed and the jejunum was collected. MPO expression from 
granulocytes of the jejunum was assessed by a fluorescence assay and 
immunohistochemistry (IHC) staining. 
Results of this study showed: (1) In the PA group, very few rolling and adhesive 
leukocytes were detected, while in the 2-ClPA treated group, there was a significant 
increase in rolling and adhesive leukocytes. At all the time points examined, 2-ClPA 
produced significant increases in mast cell degranulation, ROS production and albumin 
leakage, compared with PA. (2) In the HDA group, no increase in leukocyte rolling and 
adhesion were observed, while 2-ClHDA produced an increase in leukocyte rolling but not 
stationary adhesion. HDA produced a time-dependent increase in mast cell degranulation, 
but this was lower than that seen in response to 2-ClHDA. ROS production and albumin 
leakage were significantly lower in response to HDA than with 2-ClHDA. (3) MPO 
expression in rat jejunum was almost 2 times higher in 2-ClPA and 2-ClHDA treated 
groups compared with PA and HDA groups, respectively. Similarly, the IHC staining data 
showed that MPO expression in 2-ClPA and 2-ClHDA treated groups was more than 3-
fold higher than in PA and HDA groups, respectively.  
In summary, our data indicate that chlorinated lipid, 2-ClPA and 2-ClHDA, elicit 
inflammatory responses in rat mesentery, which are characterized by elevated leukocyte-
endothelial interactions (leukocyte rolling and adhesion), mast cell degranulation, ROS 
production, and endothelial barrier disruption (albumin leakage). These changes were 
associated with increased MPO expression level in jejunum submucosa of intestinal 
segments adjacent to the superfused mesentery in response to the two chlorinated lipid. 
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These inflammatory responses mimic those produced by sepsis, thereby providing 
evidence supporting the hypothesis that chlorinated lipid, generated from the enzymatic 
activity of neutrophil-MPO system, induce microcirculatory dysfunction via stimulating 
inflammatory responses when compared to non-chlorinated lipid. In future studies, we 
propose to directly test this postulate by applying MPO inhibitors to septic models, and 
monitoring whether chlorinated lipid production would be reduced and the aforementioned 
inflammatory responses can be attenuated.
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INTRODUCTION 
 
Preface 
Sepsis is a dangerous immune response to an infection striking adults and children of 
every age. The Centers for Disease Control and Prevention estimate that over a million 
people are hospitalized for sepsis each year, and is a major cause of morbidity and 
mortality, especially in older and immunocompromised patients. The necessity of early 
identification of sepsis lends urgency to the investigation of the pathophysiology of the 
disease and to identify reliable biomarkers. In sepsis, activated leukocytes, in particular  
polymorphonuclear neutrophils (PMNs), release an important antimicrobial enzyme, 
myeloperoxidase (MPO), which catalyzes the formation of hypochlorous acid (HOCl) 
from hydrogen peroxide (H2O2) and chloride (1; 2). Neutrophil-MPO system induces 
reactive chlorinated species (RCS) production, which can protect the host against invading 
microbes physiologically while exerting oxidative effects on plasmalogens pathologically. 
It has been demonstrated that 2-chlorohexadecanal (or 2-chloropalmitaldehyde, 2-ClHDA) 
and other chlorofatty aldehydes are produced when neutrophils are activated via the 
production of MPO-derived RCS that attack both neutrophil and endothelium plasmalogen 
pools (3). Once in the tissue, it is possible that parenchymal cells can be attacked in the 
same way by resident neutrophils activation, thereby exacerbating injury. Furthermore, as 
an intermediate of the fatty acid-fatty alcohol cycle, 2-ClHDA can be metabolized into 2-
chlorohexadecanoic acid (or 2-chloropalmitic acid, 2-ClPA) (4). 
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In sepsis, microcirculatory dysfunction is frequent, manifesting as disruption in the 
ability of the microcirculation to maintain adequate oxygen release and the delivery of 
other nutrients to tissues as well as impaired removal of metabolic byproducts, this leads 
to parenchymal cell death. The severity of microvascular alterations is associated with 
organ dysfunction and mortality. The reported main mechanisms of the development of 
microcirculatory dysfunction involves inflammatory responses, which includes endothelial 
dysfunction, impaired cell-cell communication, adhesion, rolling and emigration of white 
blood cells, mast cell degranulation, reactive oxygen species (ROS) production, and 
endothelial barrier disruption (5).  
Of note, initial investigations from our collaborative group showed that 2-chlorofatty 
acid (2-ClFA) levels in plasma were significantly greater in patients with sepsis and in a 
rat cecal ligation and puncture sepsis model. In vitro, human endothelial cells treated with 
2-ClFA species, including 2-ClPA and 2-ClHDA, demonstrated increased endothelial 
surface expression of P-selectin, E-selectin, vascular cell adhesion protein 1 (VCAM-1) 
and intercellular adhesion molecular 1 (ICAM-1). Moreover, with application of 2-ClPA 
and 2-ClHDA, human microvessel endothelial cells from lung and mesentery showed 
reduced endothelial barrier function (6). These data suggested that the chlorinated lipid 
likely play a role in the development of microcirculatory dysfunction by directly 
influencing the inflammatory response in sepsis patients. Therefore, the goal of this study 
was to further characterize microcirculatory dysfunction induced by chlorinated lipid, 2-
ClPA and 2-ClHDA, via quantifying their effects on inflammatory response including 
leukocyte/endothelial interactions (leukocyte rolling and adhesion), mast cell 
degranulation, ROS production, endothelial barrier dysfunction (albumin leakage), and the 
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expression level of MPO (a chlorinated lipid-generating enzyme released by neutrophils) 
in a rat sepsis model. This will help us better understand the function of chlorinated lipid 
involved in the microcirculatory dysfunction, and the possibility that these chlorinated lipid 
may provide reliable biochemical markers for the diagnosis of sepsis patients.  
Myeloperoxidase Derived Chlorinated Lipid Species  
Myeloperoxidase (MPO) is an important antimicrobial enzyme in azurophilic 
granules of phagocytes, and is especially enriched in neutrophils (7). Neutrophils are 
critical in bacterial killing and in clearance of invading microbes during inflammation, but 
these cells can also damage host cells when activated. In the process of neutrophil 
activation, MPO plays a central role in inducing the production of neutrophil-derived 
cytotoxic species that contribute to cell killing (8; 9). The basic function of MPO is to 
catalyze the interaction of H2O2 and chloride, to produce H2O2 to hypochlorous acid 
(HOCl) (10).  
Due to its chemical reactivity, HOCl has been shown to exert microbicidal and 
cytotoxic activity (11; 12). Thus HOCl reacting with lipids could give rise to chlorination 
of amines, alkenes and vinyl ethers (13; 14). Besides of HOCl, conjugate base (OCl-) of 
HOCl and chlorine gas (Cl2) produced by neutrophil-MPO system, comprise the major 
reactive chlorinating species (RCS) (10; 15). In equilibrium with OCl- and Cl2, HOCl 
mediates several critical reactions related to cytotoxic properties of activated neutrophils, 
by the mechanisms of oxidative bleaching of protein heme and iron sulfur centers, in 
conjunction with primary amine groups and the generation of oxidizing chloramines (16; 
17). RCS target alkene groups (-C=C-) of cholesterol or unsaturated fatty acids in 
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generation of chlorohydrins (18). It is possible that chlorohydrins and other chlorinated 
lipid-derived products partially mediate the cytotoxicity attributed to RCS (19; 20). 
In human heart tissue, nearly 30-40% of choline glycerophospholipids are 
plasmalogens, which implies that plasmalogens are a predominant phospholipid present in 
plasma membrane in cardiovascular system (21-23). In plasma membrane, plasmalogens 
are highly enriched in lipid rafts (24; 25). Endothelial cell membranes are enriched with 
plasmalogens while circulating cells such as neutrophils and monocytes also have highly 
abundant pools of plasmalogens (26; 27). Plasmalogen is characterized by the presentence 
of a vinyl ether linkage especially at sn-1 position, which is typically derived from C16:0, 
C18:0, or C18:1 fatty alcohols (21-23). The vinyl ether linkage at sn-1 is acid labile and a 
masked aldehyde. Normally, the masked aldehyde is relatively inert enzymatically, while 
being accessible in the hydrophilic plane of cell membrane bilayers where it can be targeted 
by oxidants. It has been demonstrated that plasmalogens protect mammalian cells from 
ROS attacking through putative anti-oxidant properties (21-23). On the other hand, it was 
shown that in a cell free system, plasmalogen is targeted by RCS, especially HOCl derived 
from MPO in activated leukocytes, and a neutral lipid released was identified as α-
chlorofatty aldehyde (3). In plasmalogens, such as plasmenylcholine, the sn-1aliphatic 
chain is attached to the glycerol backbone by a vinyl ether bond, which makes them 
different from the phospholipids containing esterified fatty acids. HOCl can easily attack 
to sn-1vinyl ether bond and yield a lysolipid and α-chlorofatty aldehydes (3). To be 
specific, 2-chlorohexadecanal (2-ClHDA) is formed by neutrophil-MPO-HOCl system 
attacking on the plasmalogen 1-O-hexadec-1’-enyl-2-acyl-sn-glycero-3-phosphocholine, 
while 2-chlorooctadecanal (2-ClOA) is by 1-O-octadec-1’-enyl-2-acyl-sn-glycero-3-
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phosphocholine; in neutrophils activated with PMA 2-ClOA and 2-ClHDA have been 
detected (18).  
The reports of chlorinated fatty acids and other lipids go back to at least the 1970s 
and the organohalogen compounds are widely demonstrated in biologic systems (28). 
However, halogenated compounds are considerably rarer in mammals, even though MPO 
and other haloperoxidases are present (29; 30). The formation of halogenated lipids in 
mammalian systems is not considered to be a normal physiological process but rather 
represents undesirable and damaging molecules formed in adverse conditions. Although 
some chlorinated derivatives are produced naturally in animals, in mammals the majority 
of chlorinated lipid are thought to be induced by oxidative damage in the process of 
inflammation via the action of halogenating enzymes such as MPO. To identify chlorinated 
lipid derived from phospholipids, a number of methods have been applied: 1) thin-layer 
chromatography (TLC) is applied to separate α-chlorofatty aldehydes from other 
chlorinated species or non-chlorinated lipid with comparison specific retention factors with 
synthesized standards (31); 2) gas chromatography-mass spectrometry (GCMS) has been 
extensively used for the analysis of different types of chlorinated lipid and confirms the 
formation of 2-ClHDA. The α-chlorofatty aldehydes, especially the 2-ClHDA, are  
produced via RCS, which in turn are generated by MPO in activated neutrophils, attacking 
both neutrophil and endothelial cell plasmalogen pools (18). However, it is important to 
determine whether this 2-ClHDA is of biological relevance or metabolized to functionally 
relevant molecules. 2-ClHDA Schiff base adducts have been identified and other studies 
exploring of 2-ClHDA metabolism show that neutrophils and endothelial cells can 
metabolize 2-ClHDA to 2-chlorohexadecanol (α-chlorofatty alcohol) and 2-
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chlorohexadecanoic acid (α-chlorofatty acid, 2-ClPA) (4). Despite that it could be 
metabolized within cells, the metabolites of 2-ClHDA were actively secreted outside of 
cells instead of accumulating intracellularly. At the same time, 2-ClPA can be incorporated 
by esterification into complex lipids such as triglycerides and phospholipids. In addition, a 
cell culture model of fatty aldehyde dehydrogenase (FALDH) deficiency indicated that 
FALDH was essential for conversion of 2-ClHDA to 2-ClPA. Neutrophils oxidize on 
reduce endogenously 2-ClHDA to 2-ClPA or 2-chlorofatty alcohol respectively (32). In 
conclusion, plasmalogen targeting by MPO-derived HOCl induces not only 2-ClHDA but 
also a family of chlorinated lipid including 2-ClPA and 2-chlorofatty alcohol (2-ClFOH).  
Biological Effects of Chlorinated lipid  
Important points to consider regarding the biologic relevance of chlorinated lipid is 
under what conditions and concentrations they might be produced. The possible production 
of chlorinated lipid and chlorinated fatty acids, resulting from MPO activity in the process 
of inflammatory conditions such as sepsis or I/R, are the main focus. To date, evidence 
supporting the formation of chlorinated lipid in vivo is circumstantial, with the exception 
being α-chlorofatty aldehydes. The α-chlorofatty aldehydes (α-ClFALD) contribute to 
tissue injury by the following mechanisms: 1) inhibiting eNOS (20); 2) activating NFkB 
pathway and eliciting endothelial dysfunction (33; 34); 3) promoting neutrophil 
chemotaxis (18); 4) eliciting myocardial contractile dysfunction; and 5) neuronal apoptosis 
(17; 19). However, their roles in relevant pathologic conditions have not been widely 
evaluated. 
In contrast to phospholipid chlorohydrins and chlorinated sterols, an increasing body 
of evidence shows that α-chlorofatty aldehydes are produced in vivo and increased in some 
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forms of cardiovascular disease. For one thing, in human monocytes treated with MPO or 
PMA, 2-ClHDA and 2-chlorooctadecanal (2-ClODA) were generated from LDL 
plasmalogens (35). Other work has investigated the role of 2-ClHDA in human 
atherosclerotic plaque samples, and these studies showed that 2-ClHDA levels increased 
by almost 1400 fold compared with control artery samples (36). Interestingly, 2-ClHDA 
accumulated in rat hearts after myocardial infarction induced by coronary artery occlusion, 
whereas levels were decreased in neutropenic rats.  The latter observation implied that the 
occurrence of 2-ClHDA was dependent on neutrophil infiltration (17). However, none of 
these findings demonstrates a cause and effect relationship with regard to pathologic 
mechanisms.  
So far, the main focus of research in this area have been to demonstrate potential 
effects of chlorinated lipid that might contribute to disease. For example, fatty acid 
exposure caused depletion of cellular ATP with loss of cell viability (37; 38).  Moreover, 
low micromolar concentrations of 2-ClHDA (2-10 μM) have been found to decrease eNOS 
expression in human umbilical cord endothelial cells and inhibit nitric oxide production, 
effects that could induce proinflammatory responses. Treatment with exogenous 2-ClHDA 
at the concentrations of 10-20 μM adversely affected the performance of Langendorff-
perfused rat hearts, as evidenced by decreased heart rate, and toxicity as assessed by 
elevated lactate dehydrogenase release (17). To sum up, the 2-ClHDA concentrations reach 
90 μM in phorbol ester-stimulated human neutrophils while levels estimated to be 1 μM 
occur in infarcted rat myocardium (17; 18). In plasma and phorbol ester-stimulated 
neutrophils, levels of 2-ClHDA were noted at 1 nM and 10 μM, respectively (32).  Of note, 
in human atherosclerotic lesions, 2-ClHDA levels of approximately 10 μM have been 
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calculated, which is based on 2.08 pmol 2-ClHDA/nmol lipid phosphorus and 3400 nmol 
lipid phosphorus/g wet tissue and the assumptions that 75% of the wet weight is water and 
2-ClHDA has free access to all  water space (36). The chemoattractive activity of 2-ClHDA 
has been observed at both nanomolar and micromolar levels.  Thus, it is reasonable to 
assume that 2-ClHDA at the concentration of 10 μM in vivo could be a phagocyte 
chemoattractant (6). Recent studies showed that as one component of hypochlorite-
modified LDL, 2-ClHDA induced apoptosis that was mediated by ROS in Jurkat T cells 
(27; 35; 39). Another study reported that, via the fatty alcohol-fatty acid cycle, 2-ClHDA 
forms a Schiff base and was oxidized to 2-chlorinated fatty acid, such as 2-ClPA, which 
leads to H2O2 production from THP-1 monocytes (40).  
Inflammatory Response in Microcirculation Dysfunction 
1. Chlorinated lipid are Potential Endogenous Pro-Inflammatory Molecules 
The microcirculation, comprised of vessels less than 100-300 μm in diameter 
including arterioles, venules and capillaries, with its endothelium represents the largest 
organ in the body (6). Main cellular components in microcirculation are endothelial cells, 
and smooth muscle cells (41). The microcirculation in all tissues performs essential 
homeostatic functions including oxygen delivery and solute exchange (41). The 
development of microvascular dysfunction involves endothelial dysfunction, endothelial 
barrier disruption as well as diminished production of gaseous signaling molecules, cell-
cell communication dysfunction, mast cell degranulation, and the production of ROS and 
pro-inflammatory mediators.  
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Microcirculatory functions critical for the homeostatic control of infection can 
become dysregulated and harmful during sepsis. Much evidence suggests that the defect of 
sepsis is not a loss of macrovascular blood supply but rather a loss of microvascular 
function, which has been identified as critical pathogenic endothelial barrier dysfunction, 
inappropriate neutrophil/endothelial cell interactions, ROS production and mast cell 
degranulation (42; 43). Initial investigations from our collaborative group showed that in 
septic patients, 2-chlorofatty acid (2-ClFA) levels were significantly greater in comparison 
to healthy humans. Similar observations were noted in a preclinical study with rat model 
of cecal ligation and puncture, wherein 2-ClFA level in plasma and cecum were both 
elevated compared to those with sham surgeries. Further studies conducted in cultured 
human endothelial cells demonstrated increased cell surface expression of P-selectin, E-
selectin, VCAM-1 and ICAM-1 following treatment with 2-ClHDA and 2-ClPA 
respectively, in comparison with either vehicle or equimolar HDA and PA. Moreover, 
human microvessel endothelial cells exposed to 2-ClHDA or 2-ClPA demonstrated 
increased endothelium cortical stiffness coupled with reduced endothelial barrier function. 
These observations suggested that in sepsis the potential for abundant production of 
chlorinated lipid at the neutrophil-endothelial interface make it possible that chlorinated 
lipid could be the factor mediating endothelial/microcirculatory dysfunction and eliciting 
inflammatory responses in vivo.  
Endothelial cells, which line microvasculature and macrovessels, play a central role 
in control of microcirculation, regulating leukocyte-endothelial cell interactions, leukocyte 
migration, platelet adhesion/aggregation, trafficking of nutrients and capillary permeability 
(44). Under physiological conditions, endothelial cells sense metabolic changes and 
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respond by regulating local blood flow via release of nitric oxide (NO), adjusting smooth 
muscle tone in arterioles. As an activator of soluble guanylate cyclase enzyme, NO induces 
the production of cGMP, which mediates smooth muscle cell relaxation. Whereas 
endothelial cells are activated as part of the  inflammatory response to tissue injury, with 
upregulation of inducible nitric oxide synthase (iNOS) and endothelin-1 (45; 46), the NO 
system is severely affected in sepsis. On one hand, iNOS is expressed heterogeneously, 
resulting in pathological shunt of microvascular blood supply. On the other hand, 
endothelial nitric oxide synthase (eNOS) is affected by the reactive oxygen species (ROS), 
leading to interference of NO formation and bioavailability. In addition, activated 
neutrophils can secrete proteolytic enzymes, including elastase, matrix metalloproteinases 
(MMPs), and oxygen radicals with short-term and long-term effects that produce 
endothelial dysfunction (47). Endothelial cells also lose regulatory function, contributing 
to abnormalities in microcirculation in many other ways: loss of coupling with smooth 
muscle cells, loss of electrophysiological communication between endothelial cells, and 
changes in signal transduction pathways (41; 48-50).  
2. Neutrophil-Endothelial Cells Interactions in Inflammatory Response 
The recruitment of neutrophils towards local inflammatory stimuli occurs via several 
steps (Figure 1): margination, capture (tethering), rolling, slow rolling, arrest (firm 
adhesion), luminal crawling, transendothelial migration, abluminal crawling and 
penetration of the basement membrane at low matrix protein deposition regions and 
through pericyte gaps, detachment and eventually emigration into interstitium (51). The 
neutrophil-endothelium interactions, mainly including leukocyte rolling, adhesion and 
transmigration across microvascular endothelium, occur primarily in postcapillary venules. 
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Figure 1. Neutrophils-endothelial cells interactions and MPO-HOCl-Chlorinated lipid system. Image 
courtesy of Zuidema MY, University of Missouri, Missouri, USA 
Several well-known structures exert effects on neutrophil-endothelial cell 
interactions, such as adhesion molecule expression on the surface of leukocytes and/or 
endothelial cells, electrostatic charge interactions between surface structures on both cells, 
and hydrodynamic dispersal forces that promote leukocyte margination while shear stress 
imposed by flowing blood tends to sweep these cells away from the vessel wall. In the first 
place, neutrophils exit capillaries and marginate to postcapillary venular wall under the 
guidance of hydrodynamic dispersal forces. Therefore, when adhesion molecule or 
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receptors are expressed on both cells, neutrophils tether to and roll along endothelium 
surfaces on condition that the tethering force exceeds shear forces, which can sweep non-
activated neutrophils away from non-inflamed endothelial cells. 
It is worth noting that adhesive molecules, including specific integrin members of 
immunoglobin superfamily, selectins and some other molecular entities play an import role 
in neutrophil/endothelial cell interactions (51). To be specific, E-selectin and P-selectin 
expressed on activated endothelial cells interact with L-selectin and P-selectin glycoprotein 
ligand 1 (PSGL-1) on neutrophils to mediate leukocyte rolling and adhesion. For E-
selectin, it takes 2-4 h for de novo synthesis; whereas P-selectin can move to cell surface 
directly from a stored pool in Weibel-Palade bodies, following by newly synthesized P-
selectin 1-4 h later. Thus, P-selectin is responsible for the early phase of leukocyte rolling 
while newly synthesized selectins mediate longer term rolling. Rolling leukocytes become 
activated secondary to releases of chemoattractant and intracellular signals during the 
rolling phase. The binding of integrin CD11a/CD18 on activated leukocytes surface with 
its corresponding receptor ICAM-1 on endothelial cells, works to strengthen 
neutrophil/endothelium interactions (51). Through the CD11b/CD18-ICAM-1 binding, 
neutrophils start to crawl along the vessel lumen in search of regions along the barrier for 
diapedesis. Leukocytes normally transmigrate wherever the underlying basement has low 
matrix protein deposition and usually the endothelial junction with enriched ICAM-1 
expression. In general, diapedesis via intercellular junctions involves junctional proteins, 
such as junctional molecule A and C (JAM-A and JAM-C) interacting with adhesive 
molecules CD11a and CD11b on neutrophils. After penetration, neutrophils move away 
from endothelial barrier towards pericytes via CD11a/CD11b/ICAM-1 binding, and then 
13 
 
crowd towards basement membrane through very late antigen (VLA-3/VLA-6) adhesion 
molecule mechanism. The neutrophils preferentially crawl over a gap in pericytes and low 
matrix protein area in basement membrane to detach the vessel structure (52-54).  
3. Neutrophil, Mast Cell and ROS in Inflammatory Responses 
2-ClHDA, which is a neutrophil chemoattractant, could enhance the recruitment of 
neutrophils to areas of active inflammation (3). As a critical first responder of the innate 
immune response, neutrophils are activated to kill pathogens via phagocytosis, generation 
of reactive oxygen and nitrogen species, release peptides and proteases and other hydrolytic 
enzymes to extracellular space, as well as the formation of neutrophil extracellular traps 
(NETs) (55). NETs, the end-product of this distinct form of programmed cell death termed 
“NETosis”, are networks of extracellular fibers, primarily composed of DNA from 
neutrophils, which bind pathogens (56-58). The neutrophil-MPO system could induce 
chlorinated lipid generation via plasmalogen oxidation, whereas HOCl is a ROS, generated 
from neutrophil-MPO system, that is involved in NETosis (59). In addition, mast cell 
derived tumor necrosis factor alpha (TNF α) plays an important role in inflammation 
through the recruitment and infiltration of neutrophils (60).  
Mast cells can respond to any harmful tissue injury by degranulation, which releases 
a large amount of proinflammatory stimuli, providing protection against a wide spectrum 
of microorganisms, affecting primarily the permeability of vessels by slow release of 
inflammatory mediators and chemotactic factors in the process of degranulation (61; 62). 
Secreted tryptases and chymases, such as cathepsin G, promote inflammation, matrix 
destruction and tissue remodeling by several mechanisms. However, the tryptase and 
chymases can also oppose inflammation by inactivation allergens and neuropeptides. 
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Therefore, beneficial or harmful roles of mast cells and their relative serine peptidases 
could be context-specific (63).  
ROS are oxidants derived from oxygen molecules having one or more unpaired 
electrons in atomic or molecular orbitals, which makes them highly reactive. In high 
concentrations, ROS exert damaging effects on DNA, lipids and proteins; however, at low 
concentrations ROS can cause reversible posttranslational modifications of proteins 
involved in intracellular signal transduction pathways (64-67). Interestingly, ROS play an 
important role in FcεRI-dependent signaling that provides rapid degranulation of mast cells 
(68; 69), and induce NETosis via the neutrophil-MPO system.  
4. Endothelial Barrier in Inflammatory Response 
Integrity of endothelial barrier regulates the passage of materials and the transit of 
leukocytes in and out of bloodstream, blood clotting, angiogenesis, and vasomotor 
activities in microcirculation. In most organs, the endothelial cells form a dynamic barrier, 
keeping large plasma constituents inside of the vessel, away from tissue. In resting 
conditions, the vasculature leaks small solutes continuously, but restricts extravasation of 
large molecules and cells. In pathological process, such as inflammation, the vascular 
barrier is disrupted and the leakage increases. In turn, the increased extravasation leads to 
edema and enhances the movement of blood-borne mediators, such as activated 
complement components to the tissues.  
Generally, increased ROS, diminished nitric oxide (NO), and impairment of signaling 
protein ERK5 all account for dysfunction of endothelial barrier. While the main pathways  
proposed for vascular leak is via endothelial junctions, formation of transendothelial 
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channels from vesicles or vacuoles, as well as vesiculo-vacuolar organelles (VVO) also 
contribute (70). Moreover, the actin cytoskeleton may have a critical role in gap formation 
via the retraction of the endothelium body (71). Data from our research group also showed 
that human microvessel endothelial cells exposed to exogenous 2-ClHDA or 2-ClPA 
increased endothelium cortical stiffness, which was associated with reduced endothelial 
barrier function. 
Taken together, the detrimental effects mediated by chlorinated lipid in addition to 
increased chlorinated lipid levels that have been reported under many pathologic 
conditions, suggest that during inflammatory process, chlorinated lipid are synthesized 
which in turn aggravate inflammation in a positive feedback loop. Given this correlation, 
it is apparent that more work is necessary to fully elucidate the effect of chlorinated lipid 
to elicit inflammation characterized by microcirculatory dysfunction in rat mesentery. 
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MATERIALS AND METHODS 
 
Experimental Animals 
Male Sprague Dawley rats weighing 250-300g were acquired from ENVIGO 
(Indianapolis, IN), housed in groups of two to three with a 12:12-h light-dark cycle and 
allowed access to normal diet and water ad libitum. All animal protocols were approved 
by the Institutional Animal Care and Use Committee at the University of Missouri-
Columbia and were conducted in accordance with the National Institutes of Health’s 
“Guide for the Care and Human Use of Laboratory Animals”. 
Materials 
2-ClPA and 2-ClHDA were obtained from Center for Cardiovascular Research, Saint 
Louis University. Molecular probes carboxyfluorescein diacetate, succinimidyl ester 
(CFDA SE) was purchased from Invitrogen (Eugene, OR), and Ruthenium Red was 
obtained from EMD Millipore (St Charles, MO). Dihydrorhodamine 123 (DHR 123) was 
purchased from Thermo Fisher Scientific (St. Louis, MO). Albumin-fluorescein 
isothiocyanate conjugate (FITC-albumin) and anti-MPO antibody were obtained from 
Sigma (St. Louis, MO) and Abcam (Cambridge, MA), respectively. Bicarbonate Buffered 
Saline (BBS) for exteriorized intestine and mesentery superfusion contained the following 
(in mM): 131.9 NaCl, 4.7 KCl, 2.0 CaCl2, 1.2 MgSO4, and 18 NaHCO3. PH 7.4. 
Experimental Protocol 
Rats were randomly divided into four groups, 24 animals in each group. The number 
of animals for assessment of various parameters in each group is detailed in Table 1. After 
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being anesthetized with intraperitoneal injection of a mixture of ketamine (90 mg/kg body 
wt.) and xylazine (10mg/kg), a left side abdominal incision (2-3 cm long) was performed.  
For experiments in which leukocyte/endothelial cells interactions and endothelial barrier 
function were assessed, the left jugular vein was cannulated to administer CFDA-SE and 
FITC-albumin, respectively 
Table 1. The number of animals for different experimental groups. 
 ClPA PA ClHDA  HDA 
LA, LR and MPO activity 6 6 6 6 
Mast cell degranulation 6 6 6 6 
ROS and IHC staining 6 6 6 6 
Albumin leakage 6 6 6 6 
Total 24 24 24 24 
 
 
The timeline for both treatment of chlorinated lipid and non-chlorinated lipid, and 
measurements at different time points is shown in Figure 2. At the end point, animals were 
sacrificed, then jejunum samples were collected for evaluation of MPO in fluorescence 
assay and immunohistochemistry staining. 
 
Figure 2. Timeline for different experimental groups and various parameters. 
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Intravital Microscopy 
As in previous studies, the rats were placed on a Plexiglas board, and the ileocecal 
portion of the mesentery was exteriorized and draped over a glass coverslip and superfused 
with a bicarbonate buffered saline (37°C, pH 7.4). Body temperature was maintained 
between 36.5-37.5°C. The Plexiglas board was mounted on the stage of an inverted 
microscope (Eclips TE2000; Nikon) and the post-capillary venules in mesentery were 
observed, typically with 20x magnification (51). Fluorescent images (excitation, 420-490 
nm; emission 520 nm) were detected with a charge-coupled device (CCD) camera 
(Photometrics COOLSNAP ES). Images were projected onto a television monitor (PVM-
1953MD; Sony) and recorded on a DVD recorder (DMR-E50; Panasonic) or captured 
through Metamorph software version 7.8. A time-date generator (WJ810, Panasonic) 
displayed this function on the monitor. 
Leukocyte Rolling and Adhesion 
The procedures and fluorescent labeling of leukocytes were similar to those used 
previously in our lab (72-74). Briefly, CFDA SE was injected through left jugular vein and 
the mesentery was scanned. At each time point, 10 single unbranched post-capillary 
venules (20-50 μm in diameter and 100 μm in length) were observed for at least 30 seconds. 
Leukocyte/endothelial cells interactions (number of rolling and number of firmly attached) 
were quantified in each venule followed by calculation of the mean for the 10 venules. 
Leukocytes were considered to be adherent if they did not move for at least 30 seconds. 
Rolling cells were defined to be those passing a cross line at a velocity significantly slower 
than the centerline velocity and were expressed as rolling cells per minute. The numbers 
of adherent cells were normalized in terms of mm² surface area.  
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Mast Cell Degranulation 
Ruthenium red was mixed to BBS (0.001%) and the uptake of ruthenium red was 
used as a molecular marker of mast cell degranulation (75). After being exteriorized, 
mesentery was superfused with ruthenium red in BBS for baseline evaluation, then with 
ruthenium red in chlorinated lipid or non-chlorinated lipid solutions. The mesentery was 
scanned and for each animal, the number of degranulated mast cells in 10 fields were 
recorded under intravital microscope at each time point. The number of degranulated mast 
cell at a time point to that of the baseline was designated as the ratio of mast cell 
degranulation. 
Reactive Oxygen Species Production 
The oxidant-sensitive fluorescent probe DHR 123 was added to BBS (10 μM) to 
estimate oxidant stress on post-capillary venular wall in rat mensentery. In brief, DHR 123 
in BBS was superfused over mesentery and the mesentery was scanned for the baseline 
assessment, then DHR 123 in chlorinated lipid or non-chlorinated lipid solutions was 
applied accordingly. At each time point, 10 single unbranched post-capillary venules (20-
50 μm in diameter and 100 μm in length) were observed and images were acquired. The 
fluorescence intensity was measured on the venular wall in 5 regions of interest (25 μm in 
diameter) (75). Since the baseline fluorescence intensity varies depending on the animal, 
the ratio of the fluorescence intensity at each time point to the baseline was calculated as 
DHR florescence ratio (51). 
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Albumin Leakage 
FITC-labeled albumin was used to evaluate the albumin leakage across the post-
capillary venule in rat mesenteric circulation. In brief, after left jugular vein cannulation, 
50 mg/kg of FITC-albumin was injected intravenously. After being exteriorized, mesentery 
was superfused with BBS first, and then following with chlorinated lipid or non-chlorinated 
lipid solutions. At each time point, 10 single unbranched post-capillary venules (20-50 μm 
in diameter and 100 μm in length) were selected. Images were captured, and the 
fluorescence intensity of FITC-albumin in 5 regions of interest (25 μm in diameter) within 
the venules (Iv) and in the perivenular interstitium within 10-50 μm of the venular wall (Ip) 
were measured using Metamorph software version 7.8. Albumin leakage was estimated by 
dividing Ip by Iv at each pair of corresponding circles, and the ratio of albumin leakage at 
a time point to that of the baseline was designated as the ratio of albumin leakage at that 
point (51). This method assumes that fluorescent-tagged albumin will move from the 
microvessel into the tissue space in a manner that reflects the behavior of native albumin. 
MPO activity Analysis 
 Fluorescence Assay: At the end time point of experiment, rat small intestine 
(jejunum) was collected. Tissue MPO activity was measured in small intestine samples 
with use of a fluorescence assay kit (Cell Technology, Mountain View, CA). Samples were 
prepared as per kit manufacturer’s instructions and MPO activity in the samples was 
quantified by adding the kit detection reagent and measuring the resulting fluorescence 
(excitation, 530 nm; emission, 590 nm) (76). Values were normalized to the sample protein 
content and MPO expression was expressed as milliuints per milligram protein. 
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Immunohistochemistry Staining 
The collected small intestine samples were fixed in 10% (w/v) PBS-buffered 
formaldehyde and embedded in paraffin. Following dewaxing, endogenous perioxidase 
was quenched with 3% (v/v) hydrogen peroxide for 5 min. The slides were incubated in 
5% (v/v) bovine serum for 20 min to block non-specific binding. Sections were then 
incubated with anti-MPO antibody (ab9535, 1:50 in PBS, Abcam) for 60 min. Samples 
were rinsed in wash buffer and incubated with detection system for 30 min. Slides were 
applied with DAB substrate and stained with Mayer’s hematoxylin for 30 seconds, then 
dehydrated in graded alcohol and xylene.  
Immuno-histochemical images were collected using an Olympus microscope (40x) 
and image-pro plus software version 5.1.2.59. For graphic display of staining analysis, the 
immune-reactivity was expressed as the mean total number of positive staining cells. 
Moreover, according to the grading systems for villous injury as described, the numerical 
scores were the following: 0 = normal mucosa, 1 = development of subepithelial 
Gruenhagen's space and vacuolization at the villus tip, 2 = extension of the subepithelial 
space with moderate lifting of epithelial layer from the lamina propria, 3 = massive 
subepithelial lifting/sloughing and increased vacuolization from the tip to midportion of 
villi, 4 = epithelial lifting and vacuolization from the tip to lower portion of villi, and 5 = 
mucosal ulceration and disintegration of the lamina propria (77). For each group, n=6 and 
for each animal, 10 fields were randomly chosen.  
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Statistical Analysis 
For each animal, measurements of leukocyte rolling and adhesion, mast cell 
degranulation, ROS production and albumin leakage, were transformed by normalizing 
values in response to treatment at each time point to that animal’s baseline value. 
Accordingly, the values presented for the aforementioned variables are the ratio of the 
value at each time point to the baseline. All data were shown as sample mean + standard 
error of the mean. Multiple comparisons were initially evaluated by ANOVA followed by 
Newman-Keuls to compare the change between control and treatment groups at three 
different time points. Graphpad Prism 6.0 was used to generate all statistical values. A p 
value of 0.05 or less is considered to be the level of statistical significance. 
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RESULTS 
 
Leukocyte Rolling 
To detect the leukocyte/endothelial interactions, mesentenries exteriorized from 
naive rats (n=6 for each group) were superfused with 2-ClPA or PA, 2-ClHDA or HDA 
while leukocyte rolling and adhesion were measured simultaneously. The chlorinated lipid 
promoted leukocyte rolling, however, non-chlorinated lipid treated groups failed to exert 
an effect. Specifically, at 20min, 50 min and 80 min, compared to PA group (1.7+0.68, 
1.26+0.27, 1.64+0.57), 2-ClPA group showed increased leukocyte rolling; this change 
became larger as superfusion continued (4.51+1.8, 5.80+1.12, 6.98+2.26) (Figure 3A). The 
group superfused with 2-ClHDA also showed a significant increase in leukocyte rolling 
that remained stable once elevated (4.30+0.95, 4.07+0.7, 4.64+0.79), compared to HDA 
group at each time point (1.54+0.76, 1.47+0.41, 1.96+0.75) (Figure 3B).  
 
Figure 3. Chlorinated lipid promote leukocyte rolling in vivo. The number of leukocyte rolling per mm2 
per minute were increased by superfusion of mensenteries with 2-ClPA and PA (A),  2-ClHDA and HDA 
(B). For each group, n=6; and at each time point for every animal, responses in 10 postcapillary venules from 
intestine wall were measured. ***P<0.001 between groups at indicated time point, &P<0.05 within 2-ClPA 
group, 20 min versus 80 min. 
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Leukocyte Adhesion 
Changes in leukocyte adhesion after treatment with chlorinated lipid or non-
chlorinated lipid  were also evaluated. Between 2-ClPA (5.85+3.97, 3.23+5.01, 9.83+9.43) 
and PA groups (1.07+2.61, 0.84+2.06, 6.61+7.01), as shown, leukocyte adhesion was 
increased in 2-ClPA group, which was significant only at 80 min (Figure 4A). Interestingly, 
data shows an increase trend in 2-ClHDA group, however no siginificant change was 
measured between 2-ClHDA (4.73+3.08, 2.96+1.76, 1.56+0.7) and HDA groups 
(2.38+2.62, 2.22+2.55, 5.41+2.87) at each time point (Figure 4B). 
 
Figure 4. 2-ClPA increases leukocyte adhesion. The number of leukocyte adhesion per mm2 per 30 seconds 
showing leukocyte firm adhesion in response to 2-ClPA or PA (A), 2-ClHDA or HDA (B) superfusion in 
postcapillary venule. For each group, n=6; and at each time point for every animal, 10 postcapillary venules 
from intestine wall were measured.***P<0.001 between 2-ClPA and ClPA group at 80 min. 
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Mast Cell Degranulation 
Mast cell degranulation was evaluated in perivascular interstitium for different 
groups. Representative images of non-chlorinated lipid (PA) and chlorinated lipid (2-
ClPA) superfusion evoked mast cell degranulation were shown respectively (Figure 5, 6). 
Quantitative analysis revealed that both 2-ClPA (16.02+3.59, 19.0+4.7 and 20.37+4.83) 
and 2-ClHDA (8.03+0.1, 8.22+0.2, 7.71+0.28) provoked enhancement in mast cell 
degranulation, whereas PA exerted less effect (3.26+0.6, 3.83+0.5 and 4.08+0.41) (Figure 
7A). Our data also showed that HDA (3.45+0.9, 4.2+1.04 and 5.00+1.2) superfusion 
induced an increasing trend of mast cell degranulation over time. (Figure 7B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5. Representative images of mast cell degranulation responding to PA superfusion. A: baseline, 
no degranulated mast cells were detected in rat mesentery. In contrast to 2-ClPA, PA produced very little or 
no mast cell degranulation after 20 (B), 50 (C) or 80 (D) min superfusion. Yellow arrow indicates 
degranulated mast cells. Scale bars=25 μm. 
A B 
C D 
25 μm 25 μm 
25 μm 25 μm 
PA Baseline PA 20 min 
PA 50 min PA 80 min 
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Figure 6. Representative images of mast cell degranulation responding to 2-ClPA superfusion. A: 
baseline, no degranulated mast cells were detected in rat mesentery. B: superfusion with 2-ClPA for 20 min, 
mast cell degranulation were detected, which increased after superfusion for 50 min (C) and 80 min (D). 
Yellow arrow, indicates degranulated mast cells. Scale bars=25 μm. 
 
Figure 7. Mast cell degranulation changes with chlorinated lipid superfusion. The number of 
degranulated mast cell per field, in response to 2-ClPA or PA (A),  2-ClHDA or HDA (B) superfusion in peri-
postcapillary venules were counted. Respective mean value at different time point was normalized to the 
baseline, shown as sham group here. For each group, n=6; and at each time point for every animal, 10 fields 
(20x) along mesenteric venules were measured. ***P<0.001, **P<0.01 between groups at indicated time 
point. 
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ROS Production 
When fluoresence intensity of DHR 123 in the venular walls was initially measured, 
no or very little DHR fluoresence was detected on rat mesenteric venular walls at baseline. 
Chlorinated lipid induced a pronounced DHR fluoresence on mesenteric venular walls, and 
the representative images of 2-ClHDA group are illustrated in Figure 8 (A-D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 8. Representative images of ROS production on mesenteric venular wall.  A: baseline, no DHR 
fluoresence is visible. B: 20 min after 2-ClHDA superfusion, detectable DHR fluoresence shows on the rat 
mesenteric venule wall. C: 50 min after 2-ClHDA superfusion, more fluorescence is showing on venular 
wall. D: 80 min after superfusion, the fluoresence are much brighter. White arrow indicates mesenteric 
venule. Scale bars=25 μm. 
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Specifically, with 2-ClPA treatment, DHR fluoresence was elevated throughout the 
superfusion with this chlorinated lipid (2.48+0.91, 2.28+0.42 and 2.41+0.33) (Figure 9A). 
Moreover, the fluoresence intensity after 2-ClHDA treatment was also increased over time 
(1.71+0.14, 2.08+0.13, 2.59+0.26), being especially prominent at 80 min when compared 
to that at 20 min (Figure 9B). On the contrary, in the non-chlorinated lipid groups, there 
was no significant changes in the DHR fluoresence ratio on the venular wall throughout 
the observation. Specifically, the fluoresence ratio was 1.20+0.26, 1.51+0.48 and 
1.34+0.28 in PA group, and 1.07+0.13, 1.23+0.1 and 1.33+0.16 in HDA group at 20 min, 
50 min and 80 min respectively. 
 
Figure 9. Chlorinated lipid increase ROS production in mesentery. The ratio of DHR 123 fluorescence 
intensity along the vesule wall at each time point to that at baseline indicated reactive oxygen species 
production responding to 2-ClPA or PA (A), 2-ClHDA or HDA (B) superfusion in mesentery. For each group 
(n=6), at each time point for every animal, 10 mesenteric venules were randomly chosen and 5 regions of 
interest (25 um in diameter) along venule wall were measured. ***P<0.001, **P<0.01, *P<0.05 between 
groups at indicated time point, &P<0.05 within 2-ClHDA group, 20 min versus 80 min. 
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Albumin Leakage 
The representative images of FITC-labeled albumin leakage from rat mesentery 
venules challenged with chlorinated lipid are presented (Figure 10). No or very limited 
albumin leakage was observed at baseline, whereas leakage was apparent when observed 
at 20 min, 50 min and 80 min with chlorinated lipid superfusion (Figure 10 A-D).  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10. FITC-labeled albumin leakage from rat mesentery venules. A: baseline, all FITC-labeled 
albumin is localized within venule, and no labeled albumin is visible in the perivenular interstitium. B: 
superfused with 2-ClHDA for 20 min, detectable fluoresence shows in the perivenular interstitium (Ip) while 
decrease fluoresence within venules (Iv). C: 50 min with 2-ClHDA superfusion, with an increase in Ip, 
fluorescence intensity decreases in Iv. D: superfusion for 80 min, the comparison between Ip and Iv is more 
obvious. White arrow indicates postcapillary venules in rat mesentery. Scale bars=25μm. 
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The albumin leakage from the rat mesenteric venules was quantitated and graphed 
against time (Figure 11). The albumin leakage was very low or even undetectable before 
lipid treatment in all groups, and this situation persisted throughout the observation period 
in mesenteric superfused with PA (1.11+0.21, 1.08+0.16 and 1.03+0.04) or HDA 
(0.98+0.05, 0.97+0.15 and 1.07+0.17). On the other hand, in the 2-ClPA (3.19+0.003, 
3.56+0.19 and 4.0+0.17) and 2-ClHDA (2.13+0.49, 2.7+0.53, 3.21+0.6) group, albumin 
leakage from venules increased immediately after the initiation of chlorinated lipid 
superfusion in a time-dependent manner.  
 
Figure 11. FITC-albumin leakage in mesenteric microcirculation along with chlorinated lipid 
treatment. The fluoresence intensity within mesenteric postcapillary venules (Iv) and in perivenular 
interstitium (Ip) in response to 2-ClPA or PA (A),  2-ClHDA or HDA (B) superfusion were measured. For 
each group (n=6), at each time point for every animal, 10 mesenteric venules were randomly chosen and 5 
regions of interest (r=12.5 mm) along venule wall were measured. The ratio of Ip/Iv was calculated at each 
coresponding cirle, and mean value of the ratio at each time point was normalized to baseline. **P<0.01, 
*P<0.05 between groups at indicated time point. 
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MPO Activity Assay  
In addition to the aforementioned indices of inflammation which were shown to 
increase after chlorinated lipid exposure, we also assessed MPO levels as a marker of 
neutrophil infiltration. Rat small intestine, when subjected to chlorinated lipid superfusion 
till the end of experiment, contained more abundant brown staining compared to non-
chlorinated lipid groups, as determined by immunohistochemistry staining and revealed by 
high magnification (40x). Of note, when compared 2-ClPA to PA, or 2-ClHDA to HDA, 
in submucosa of small intestine more MPO was detected in chlorinated lipid groups (Figure 
12, A-D). However, based on the staining, no significant injuries was observed in 
epithelium of small intestine in four groups (data were not shown here).  
 
Figure 12. IHC staining for MPO in small intestine. Immunohistochemistry staining of myeloperoxidase 
in rat small intestine, as shown in brown staining. A: 2-ClPA; B: PA; C: 2-ClHDA; D: HDA. Yellow arrow 
head indicates positive staining (brown) cells. Scale bars=50 μm. 
B 
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2-ClPA  A PA  
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50 μm 
2-ClHDA  C 
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Quantitative analysis of IHC staining for MPO in submucosa of rat small intestine 
exposed to 2-ClPA (37.07+5.46) or 2-ClHDA (40.28+4.75) induced increased positive 
staining cells in relative to control groups as shown (PA: 12.53+1.6; HDA: 12.98+1.25) 
(Figure 13A). Given the markedly increased MPO staining in rat mesentery superfused 
with chlorinated lipid, we explored the putative effect of chlorinated lipid on MPO activity 
in the mucosa. Similar to our IHC results, MPO levels were significantly increased in 
chlorinated lipid treated animals (2-ClPA: 1434.46+243.82; 2-ClHDA: 1568.4+409.18) 
compared with the non-chlorinated controls (PA: 818.86+95.97; HDA 720.24+102.31) 
(Figure 13B). 
 
Figure 13. MPO activity after chlorinated lipid challenge. A: Quantification of IHC positive staining cells 
for MPO in small intestine collected at the end time point. For each group (n=6), 10 fields under microscpoe 
(40x) focused on submucosa were randomly chosen. B: Tissue MPO activity was analyzed by measuring 
resulting fluoresence at 530 nm (exitation) and 590 nm (emission). The measurements were reapeated for 
three times and mean values were normalized for sample protein content (n=6). ***P<0.001, *P<0.05 
between groups at indicated time point. 
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DISCUSSION 
The primary purpose of this study was to test the hypothesis that, when compared to 
mesenteric superfusion with non-chlorinated lipid, rat mesenteries will exhibit endothelial 
and microcirculatory dysfunction in response to chlorinated lipid. Impaired 
microcirculatory function with increased plasma 2-chlorofatty acid (2-ClFA) level is well 
established in septic patients and the rat cecal ligation and puncture model of sepsis. 
However, the link between elevated chlorinated lipid levels and development of 
microcirculatory dysfunction has not been established. Moreover, the mechanisms 
underlying such sepsis-induced changes in vivo are multi-factorial and complex due to 
integration of several proinflammatory factors and the involvement of multiple organs. For 
instance, microbial invasion in sepsis elicits powerful immune responses that involve 
release of pro-inflammatory mediators, over-exuberant production of reactive oxygen 
species (ROS), mast cell degranulation, leukocyte-endothelial cell interactions, and 
microvascular barrier disruption that serve as a motor for multi-organ failure when these 
responses extend systemically. Microcirculatory function is severely compromised in 
sepsis, which further aggravates inflammation. Neutrophil/endothelial cell interactions, 
characterized by increased leukocyte rolling and adhesion along the lumen of post capillary 
venules followed by emigration into the tissues where they direct a focused attack on 
parenchymal cells, is a major contributor to cell dysfunction. Given these considerations, 
we wished to determine the local effects of exposure to chlorinated lipid in the absence of 
confounding compromise in the function of multiple organs, as occurs in sepsis. 
One of the hallmark feature of inflammation is endothelial barrier dysfunction, or 
disrupted endothelial barrier in microcirculation. This is especially problematic for the 
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lungs, where edema formation and alveolar flooding impairs gas exchange. Chlorinated 
lipid associated inflammatory response may cause alterations in microcirculatory 
functions; however, it is difficult to rigidly isolate all systemic variables in vivo. The 
working model in naïve rats with local exposure of only a small region of mesentery allows 
independent, precise superfusion (shown in Table 1) under experimentally controlled 
conditions, enabling direct treatment of chlorinated lipid, 2-ClPA and 2-ClHDA, or non-
chlorinated lipid, PA and HDA as controls, as a result, and examination of inflammatory 
responses. This avoids the complications associated with impaired gas exchange and 
resulting hypoxia in the production of inflammatory responses secondary to production of 
chlorinated lipid. This study quantified the inflammatory response of rat mesentery to 
chlorinated and non-chlorinated lipid superfusion via intravital microscopy.  
In addition, with chlorinated lipid superfusion, endothelial barrier dysfunction was 
observed in microvessel endothelial cells while increased cell surface expression of P-
selectin, E-selectin, VCAM-1 and ICAM-1 in cells treated with 2-ClHDA and 2-ClPA in 
human endothelial cell. While in vitro measurement allows monitoring of immediate effect 
on endothelial dysfunction and endothelial barrier disruption induced by chlorinated lipid, 
it is more difficult to predict the relationship between chlorinated lipid and inflammation 
due to the complex environment in the body, wherein several cell types, mediators release 
from the extracellular matrix, and parenchymal cell injury all contribute to systemic 
inflammation. Therefore, we sought to directly measure the pro-inflammatory effects of 2-
ClPA or 2-ClHDA on the intact microcirculation in vivo to measure neutrophil/endothelial 
cell interactions, ROS production, and mast cell degranulation and albumin leakage 
directly with controlled superfusion in vivo.  
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As predictive, we uncovered two distinct responses in rat mesentery. The first 
consisted of rats which responded to 2-ClPA and 2-ClHDA respectively with an increase 
in leukocyte-endothelium interactions and a second group, which responded to PA and 
HDA respectively without an increase in leukocyte-endothelium interactions. These 
experiments showed profound differences in leukocyte rolling and adhesion with different 
superfusion challenges. E-selectin and P-selectin expressed on activated endothelial cells 
could interact with L-selectin and P-selectin glycoprotein ligand 1 (PSGL-1) on neutrophils 
to mediate leukocyte rolling and adhesion (51). Previous studies by McHowat et al have 
shown that human endothelial cells treated with 2-ClPA or 2-ClHDA had significantly 
increased surface expression of P-selectin, E-selectin, VCAM-1 and ICAM-1. In addition, 
CD62L and CD66b are adhesion molecules expressed on activated neutrophils, allowing 
their adherence to endothelial cells. Moreover, binding of integrin CD11a/CD18 on 
activated leukocytes surface with responding receptor ICAM-1 on endothelial cells, works 
to strengthen neutrophil/endothelial cell interactions (51). Although in vitro measurements 
including isolated postcapillary venules and cell culture models incorporating shear stress 
exposure (78-80), have the advantage of assessing individual contribution to leukocyte-
endothelial cells interactions, in vivo working mesentery preparations give the advantage 
of describing microcirculation function within the organism and allowing investigation the 
effect of chlorinated lipid with associated neuronal and humoral modulation of 
microcirculation. Increased leukocyte rolling and adhesion occurred in response to 
mesenteric superfusion with chlorinated lipid.  
Similarly, both 2-ClPA and 2-ClHDA superfusion promoted mast cell degranulation 
when compared to the non-chlorinated lipid treatment groups. It has been shown by others 
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that chloride and hypochlorite products from MPO-H2O2-chloride system promote 
neutrophil extracellular trap (NETs) formation, which is responsible for immobilizing and 
killing invading microbes (59). Activated neutrophils could also secrete oxygen radicals as 
well as proteolytic enzymes, including serine protease proteinase-3 (PR-3), elastase and 
cathepsin G, leading to endothelial cell injury (81). Moreover, 2-ClHDA could mediate 
microvascular endothelial cell dysfunction, such as loss of barrier function, mitochondrial 
dysfunction, and apoptosis (34). Of note, based on the likely interaction between mast cells 
and neutrophils, the granular content of mast cells such as proinflammatory mediators and 
cytokines, could be released through a “kiss and run” mechanism (82). Kiss-and-run 
fusion is a type of vesicle release or exocytosis where the vesicle docks and transiently 
fuses at the plasma membrane and releases its granule contents, after which the vesicle can 
then be reused. The process of mast cell degranulation can be mediated by both immune 
and non-immune pathways. The immune pathway is usually activated by aggregation of 
specific surface receptors FcεRI binding with several complexes of antigens with IgE. The 
γ-chains of the receptor mediating signal transmission, leads to an increase in 
Ca2+concentration in the cytosol, which initiates degranulation and synthesis of new 
mediators. On the contrary, non-immune pathways are triggered by cytokines, chemokines, 
components of cell wall and some other substances (61; 83). Secreted tryptases and 
chymases from mast cells could promote inflammation, matrix destruction and tissue 
remodeling via destroying pro-coagulant, activating proteinase-activated receptors, and 
promoting the conversion of angiotensin I to angiotensin II (63).  
In addition to enhanced leukocyte-endothelial adhesive interactions and mast cell 
degranulation, we also noted reactive oxidative species (ROS) production in postcapillary 
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venules on mesenteric exposure to 2-ClPA and 2-ClHDA challenges, respectively. Based 
on these results, we postulated that chlorinated lipid are associated with ROS production 
in vivo. The mechanisms underlying this ROS production could fall into one of several 
categories. 2-ClHDA has been shown to be a potent neutrophil chemoattractant, inhibitor 
of endothelial nitric oxide synthase (eNOS), inducer of the expression of cyclooxygenase-
2 (COX-2) and mediator of endothelial cell dysfunction (84-87). By these mechanisms, 
activated neutrophils could potentially play a role in the observed changes in ROS 
production. Activated neutrophils consume oxygen to generate an array of damaging 
reactive oxidizing species such as superoxide anions and hydrogen peroxide (10; 88). As 
previously mentioned, hydrogen peroxide is released concomitant with the release of heme 
protein MPO for production of hypochlorous acid (HOCl). A further explanation of ROS 
production could also include endoplasmic reticulum (ER) stress. It should be noted that 
2-ClHDA can be oxidized intracellularly to 2-ClPA, which solely can lead to H2O2 
production from THP-1 monocytes (80). The application of the antioxidant, N-
acetylcysteine (NAC) and glutathione (GSH) alleviated release of H2O2 induced by 2-ClPA 
(80), and attenuated 2-ClPA induced caspase 3 activity, poly ADP-ribose polymerase 
(PARP) cleavage and CCAAT/enhancer-binding protein homologous protein (CHOP). 
The interplay between ROS and ER stress has been reported in many studies, while the 
detailed mechanism is still not well understood (89; 90). Investigation of α-tocopheryl 
succinate-treated human gastric carcinoma cells implied that ROS generation decrease 
results from attenuation of ER stress, and the major pathways involved are inositol 
requiring enzyme-1 (IRE1) and RNA-dependent protein kinase-like ER kinase (PERK) 
(91). In addition, the effect of chlorinated lipid to induce mast cell degranulation may result 
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in chymase release. This enzyme catalyzes the conversion of angiotensin I to angiotensin 
II, a known activator of NADPH oxidase. 
Our work also shows that chlorinated lipid also increased vascular permeability. Here 
the data showed that in the 2-ClPA and 2-ClHDA group, albumin leakage from venules 
increased immediately after the initiation of chlorinated lipid superfusion in a time-
dependent manner. In general, increased ROS, diminished nitric oxide (NO), and 
impairment of signaling protein ERK5 may all contribute to dysfunction of endothelial 
barrier. The main pathways for vascular leak of protein like albumin, include endothelial 
junctions, vesicular shuttling, and/or formation of transendothelial channels from vesicles 
or vacuoles into vesiculo-vacuolar organelles (VVO) (70). The paracellular junctions lie 
between endothelial cells are organized into adherens and tight junctions, and the main 
component of adheren junctions is vascular endothelial (VE)-cadherin, forming 
homophilic complexes (92). Adherens junctions dissolve in response to inflammatory 
cytokines such as histamine and bradykinin, allowing extravasation of macromolecules. 
The mechanisms under this involves VE-cadherin dissolution, which may result from 
direct or indirect phosphorylation mediated by activation of c-Src (93). However, the 
mechanism of VE-cadherin internalization remains to be identified (94). In addition, the 
VVO is a distinct endothelial cell structure that provides a transcellular pathway for 
macromolecular extravasation in endothelial transcytosis under particular conditions (95-
97). Vesicles and vacuoles that make up VVO were originally thought to derive from 
caveolae, with caveolin-1 as the main protein. However, the fact that caveolin-1 knock-out 
mice still exhibit VVOs in vasculature, implies caveolin-1 may not be required for VVO 
formation.  
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In addition to these mechanisms, the actin cytoskeleton may have a critical role in 
gap formation via the retraction of the endothelium body (71). Our laboratory has also 
showed that human microvessel endothelial cells exposed to exogenous 2-ClHDA or 2-
ClPA treatment showed increased endothelium cortical stiffness, which coincided with 
reduced endothelial barrier function. The mechanisms could be action of intracellular 
motor proteins facilitates opening of paracellular junctions. It is also possible that the cell 
shape changes could be a natural recoil occurring during paracellular junctions disassembly 
(98; 99). Small guanosine triphosphatases (GTPase) from the ras superfamily, primarily 
Rho GTPases (RhoA, Rac1, Cdc42) or Rap1, affect microvascular permeability via 
reorganization of junction-associated cortical actin cytoskeleton. Specifically, Rac1 and 
Cdc42 are the main GTPases required for barrier maintenance and stabilization, while 
RhoA negatively regulates barrier functions (100-103). It is also known that cAMP 
signaling enhances barrier functions partially via Rap1 mediated activation of Rac1 and 
Cdc42 as well as inhibition of RhoA (104). Inhibition of these signaling pathways by 
chlorinated lipid may also underlie the increased permeability. Clearly, much additional 
work will have to be undertaken to address these intriguing hypotheses. 
We hypothesized that compared to non-chlorinated lipid, chlorinated lipid could elicit 
inflammation via a positive feedback cycle via the activation of neutrophil-MPO system. 
Based on our IHC staining and MPO fluorescence assay, MPO level was significantly 
increased in chlorinated lipid treated animals compared with the non-chlorinated controls. 
This key enzyme, primarily derived from activated neutrophils, induces endothelial 
dysfunction and caspase activation resulting in human endothelial cells apoptosis via 
oxidative stress (105-107). It has been suggested that MPO in neutrophils diminishes the 
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toxic effects and mortality in sepsis model induced by lipopolysaccharide (108). The 
underlying mechanisms could be that MPO binds to and activates neutrophils, supports cell 
adhesion, and prolongs neutrophil survival via interactions with CD11b/CD18 integrin and 
electrostatic interactions (109-112). MPO binds to red blood cell membranes, and is 
transported by red blood cells to remote sites, affecting endothelial function as well as 
systemic vascular resistance (113). However, MPO can also have anti-inflammatory effects 
directly by its catalytic action, via the oxidative modification or destruction of soluble 
mediators, such as high-mobility group protein 1 (HMGB1) (114; 115). Based on this, 
further study will test whether preventing MPO-induced chlorinated lipid production could 
reduce inflammatory injury in vivo.  
In the current studies, we showed that 2-ClPA and 2-ClHDA caused similar 
endothelial responses and ROS production in the rat mesenteric microcirculation, while 2-
ClPA induced more mast cell degranulation at all the time points and albumin leakage at 
20 min and 50 min. Other studies have demonstrated that neutrophils and endothelial cells 
can metabolize 2-ClHDA (an α-chlorofatty aldehyde) to 2-ClPA (an α-chlorofatty acid) 
and 2-ClFOH (an α-chlorofatty alcohol) (4). Reaction of α-chlorofatty aldehydes with the  
nucleophile glutathione (GSH) in activated human neutrophils and in vivo has been shown 
to promote the formation of glutathione adducts (116). On the other hand, α-chlorofatty 
aldehydes can also elicit functional changes in targeted cells though Schiff-base adduct 
formation with primary amines of proteins and lipids (117). In this regard, 2-ClHDA 
Schiff-base adducts with ethanolamine glycerol-phospholipids and lysine have been 
identified (118). Although 2-ClHDA and 2-ClPA can act as a chemoattractant and a 
chemorepellant, respectively, for neutrophils, both of 2-ClHDA and 2-ClPA increase 
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endothelial COX-2 levels (32) (18). Since 2-ClHDA can be converted to 2-ClPA, it is 
possible that the effect of 2-ClHDA exposure to increase NF-κB dependent COX-2 
expression may be mediated by this secondarily derived metabolite, rather than 2-ClHDA 
per se (32; 33). This is a possible explanation for higher mast cell degranulation and 
albumin leakage induced by 2-ClPA when compared with 2-ClHDA. However, the relative 
contributions of 2-ClHDA versus its metabolites on these responses remain to be 
investigated.                                                                                                                                         
Local superfusion with chlorinated lipid allows examination of local inflammatory 
responses that are not likely complicated by systemic effects (however, see below). 
Nevertheless, several limitations of the working model are notable. The mesentery was the 
site of exposure to chlorinated lipid. Therefore, the inflammatory responses we observed 
represent local inflammatory responses that are not influenced by effects of systemic 
exposure to chlorinated lipid that characterizes sepsis. For one thing, superfusion of the rat 
mesentery with compounds is a well-established delivery system, which implies that 
chlorinated lipid superfused could be absorbed rapidly via mesenteric microcirculation 
causing systemic inflammation. However, the mesenteric surface area is small in our 
model. For another, Paul et al indicated that following a sterile injury to visceral organs, a 
reservoir of fully mature peritoneal cavity macrophages can respond within an hour (119). 
In this case, we could explain our results as chlorinated lipid activate macrophages or 
neutrophils, leading to the increase of MPO and other inflammatory responses that extend 
beyond local exposure. Other drawbacks of using the exteriorized mesentery superfusion 
method include vulnerability to injury during exteriorizing procedures and throughout the 
protocol, increased reactive oxidative stress and progressive loss of mesentery function 
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over time as a result of tissue exposure. As noted above, the inflammatory milieu is 
characterized by a larger number of factors extrinsic to the postcapillary venular walls that 
influence neutrophil/endothelial cell interactions, venular permeability responses and so 
on. It is necessary to perfect our approaches that allow precise control of these external 
factors, making the individual contributions to mesenteric microcirculation dysfunction 
more reliable.  
The result of our study represents the first in vivo characterization of inflammatory 
responses. Further experiments elucidating the mechanisms underlying these responses and 
examining other pro- and anti- inflammatory mediators are required to explain how these 
microcirculatory alterations occur. Given the observations of increased P-slectin, E-
selecin, ICAM-1 and VCAM-1 in human endothelial cells with 2-ClPA and 2-ClHDA 
treatment, subsequent experimentation will consist of western blotting in tissue samples 
from animals to quantify adhesion molecules expression change with 2-ClPA and 2-
ClHDA superfusion in vivo, respectively. Given the possibility of chlorinated lipid-
neutrophil activation-MPO-chlorinated lipid positive feedback loop, further 
experimentation could also be performed to specifically block myeloperoxidase (MPO) 
oxidation in rat sepsis model with N-acetyl lysyltyrosylcysteine amide (KYC) (Figure 14). 
Under inflammation ablation in septic rats would explain that in sepsis, chlorinated lipid 
elicit inflammation via a positive feedback way to activate neutrophils entering into MPO-
HOCl-chlorinated lipid loop.   
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Figure 14. Hypothesis of 2-Cl. lipids elicit inflammation via positive feedback in sepsis. 
 
In conclusion, chlorinated lipid induce a number of inflammatory responses in rat 
mesentery, including increased neutrophil/endothelial cell interactions, mast cell 
degranulation, ROS production and disrupted endothelial barrier. On the contrary, non-
chlorinated lipid did not produce these responses. Future studies will endeavor to determine 
the targets of the different chlorinated lipid and/or specific receptors, identify underlying 
inflammatory mechanisms and determine whether these compounds could serve as reliable 
biomarkers and mediators for diseases likely to involve production of these lipid mediators 
such as sepsis or ischemia/reperfusion. 
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